目的研究总结隐匿性肝硬化患者的多种首发临床症状。方法分析总结经临床确诊的110例隐匿性肝硬化患者的临床资料。结果110例隐匿性肝硬化中男92例,占83.6%,女18例,占16.4%。肝损伤33例,占30.0%;输液后腹水、浮肿18例,占16.4%;胆石症17例,占15.5%;腹泻15例,占13.6%;肝癌14例,占12.7%;上消化道出血11例,占10.0%;皮疹2例,占1.8%。结论对于隐匿性肝硬化各种首发症状,临床医师应高度警惕,认识其复杂性。提早首次诊断的时间,对患者延长生存时间,提高生活质量 ...
彭定宏
doaj
乙型肝炎病毒(HBV)是引发肝硬化的重要原因之一,乙型肝炎后肝硬化是我国常见的消化系统疾病之一,近年来发病率呈逐渐上升趋势,早期病情常处于代偿期,临床症状不明显,缺乏特异性的检查方法,患者易错过最佳诊断时机,严重影响患者的生活质量和生存时间。因此,及时发现、正确诊断、及时治疗乙型肝炎后肝硬化对改善患者预后有着重要的临床意义[1 ...
杨进山, 王宏旭
doaj
目的获得重组HBx蛋白,检测乙型肝炎患者血清抗HBx抗体并探讨其临床意义。方法利用分子克隆技术克隆HBVX基因构建PET32aHBX原核表达载体,表达和纯化HBx蛋白,用该重组蛋白建立检测抗HBx抗体的间接ELISA方法;采用该ELISA分别检测正常人组、急性肝炎组、慢性肝炎组、肝硬化组和肝细胞癌组患者血清中的抗HBx抗体。结果获得具有免疫原性的HBx融合蛋白;ELISA检测表明,慢性肝炎组、肝硬化组和肝细胞癌组的抗HBx抗体的水平均高于急性肝炎组,差异具有显著性;在这三组之间 ...
任锋 +6 more
doaj
[Interpretation of the <i>Guidelines for Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Liver Cirrhosis</i>]. [PDF]
Lyu W, Cao Z, Ye Y, Xing L.
europepmc +1 more source
[Animal Modeling of Osteoporosis Combined With Liver Cirrhosis and Preliminary Investigation of the Comorbidity Mechanisms]. [PDF]
Pei T +6 more
europepmc +1 more source
[Abnormal elevation of growth hormone in patients with pituitary adenoma combined with cirrhosis: A case report]. [PDF]
Wang Y, Duan M, Xiao J, Zhao W.
europepmc +1 more source
[Risk assessment of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis and hypertension: a propensity score matching-based retrospective cohort study]. [PDF]
Hu J, DU F, Ding L, Wang L, Zhao W.
europepmc +1 more source
[LncRNA Meg3 expression level is negatively correlated with liver fibrosis severity in patients with Wilson disease]. [PDF]
Hua D +8 more
europepmc +1 more source
肝炎后肝硬化患者尿血栓素B2和6-酮-前列腺素F1α与肾功能的关系
用放射免疫法测定了45例肝炎后肝硬化患者尿血栓素B2和6-酮-前列腺素F1α的排泄率。结果,肝硬化患者尿血栓素B2排泄率较正常对照明显升高;肝硬化无并肾衰者尿6-酮-PGF1α较对照组升高;但并有肾衰者尿6-酮-前列腺素F1α排泄率比无并肾衰者则显著降低 ...
doaj
A Chinese question and answer system for liver cancer based on knowledge graph and large language mode. [PDF]
Wu H +8 more
europepmc +1 more source

